iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Sees Large Decrease in Short Interest

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a significant drop in short interest in February. As of February 27th, there was short interest totaling 2,917 shares, a drop of 39.3% from the February 12th total of 4,809 shares. Based on an average daily trading volume, of 969 shares, the days-to-cover ratio is presently 3.0 days. Currently, 1.9% of the company’s stock are sold short. Currently, 1.9% of the company’s stock are sold short. Based on an average daily trading volume, of 969 shares, the days-to-cover ratio is presently 3.0 days.

iShares Neuroscience and Healthcare ETF Price Performance

Shares of NYSEARCA:IBRN traded down $0.55 during midday trading on Friday, reaching $31.00. The company had a trading volume of 5,302 shares, compared to its average volume of 2,139. The stock has a market capitalization of $4.65 million, a P/E ratio of 15.61 and a beta of 0.93. The stock’s fifty day moving average price is $32.20 and its 200-day moving average price is $30.12. iShares Neuroscience and Healthcare ETF has a one year low of $17.86 and a one year high of $37.00.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.